Dosing regimen rationalization of biapenem in pediatric patients: Use of Monte Carlo simulation

Japanese Journal of Antibiotics

Volumn 62, Issue 1, 2009, Pages 1-8

  Kameda, Keiko ^a   Miki, Mizuka ^a   Ikawa, Kazuro ^a   Morikawa, Norifumi ^a   Kobayashi, Masao ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIAPENEM; CREATININE; THIENAMYCIN DERIVATIVE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ARTICLE; BIOLOGICAL MODEL; BODY WEIGHT; CHILD; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLIC CLEARANCE RATE; MONTE CARLO METHOD; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; REGRESSION ANALYSIS; STREPTOCOCCUS PNEUMONIAE; URINE;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CREATININE; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; MONTE CARLO METHOD; PSEUDOMONAS AERUGINOSA; REGRESSION ANALYSIS; STREPTOCOCCUS PNEUMONIAE; THIENAMYCINS;

EID: 66149106278     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. CRAIG, W. A.: Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin. Infect. Dis. 26: 1-12, 1998 (Pubitemid 28068148)
2. AMBROSE, P. G. & D. M. GRASELA: The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 38: 151-157, 2000
3. KOEPPE, P.; D. HOFFLER & B. FITZEN: Biapenem pharmacokinetics in healthy volunteers and in patients with impaired renal fonction. Arzneim.-Forsch. 47: 1250-1256, 1997 (Pubitemid 27514567)
4. TRAUB, S. L. & C. L. JOHNSON: Comparison of methods of estimating creatinine clearance in children. Am. J. Hosp. Pharm. 37: 195-200, 1980
5. DUOIS, D. & E. F. DUOIS: A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 17: 863-871, 1916
6. IKEDA, K.; K. IKAWA, A. IKEDA, et al: A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 844: 148-152, 2006 (Pubitemid 46048603)
7. DRUSANO, G. L.: Prevention of resistance: a goal for dose selection for antimicrobial agents. Clin. Infect. Dis. 36 (Suppl. 1): S42-S50, 2003 (Pubitemid 36140468)
8. PERRY, C. M. & T. IBBOTSON: Biapenem. Drugs 62: 2221-2234, 2002 (Pubitemid 35252832)
9. TAKATA, T.; K. AIZAWA, A. SHIMIZU, et al.: Optimization of dose and dose regimen of biapenem based on pharmacokinetic and pharmacodynamic analysis. J. Infect. Chemother. 10: 76-85, 2004 (Pubitemid 38590729)